4.8 Article

Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer Immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Top 10 Challenges in Cancer Immunotherapy

Priti S. Hegde et al.

IMMUNITY (2020)

Article Nanoscience & Nanotechnology

Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo

Lu Zhang et al.

NATURE NANOTECHNOLOGY (2020)

Review Chemistry, Multidisciplinary

Supramolecular Self-Assembled Nanostructures for Cancer Immunotherapy

Zichao Huang et al.

FRONTIERS IN CHEMISTRY (2020)

Article Nanoscience & Nanotechnology

Programmable multistage drug delivery to lymph nodes

Alex Schudel et al.

NATURE NANOTECHNOLOGY (2020)

Review Oncology

Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms

Wantong Song et al.

TRENDS IN CANCER (2020)

Review Chemistry, Multidisciplinary

Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

Xiaopin Duan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Review Nanoscience & Nanotechnology

Material design for lymph node drug delivery

Alex Schudel et al.

NATURE REVIEWS MATERIALS (2019)

Article Chemistry, Multidisciplinary

Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy

Qian Chen et al.

ADVANCED MATERIALS (2019)

Review Nanoscience & Nanotechnology

Leveraging biomaterials for cancer immunotherapy: targeting pattern recognition receptors

W. Song et al.

MATERIALS TODAY NANO (2019)

Article Biotechnology & Applied Microbiology

A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

Suping Li et al.

NATURE BIOTECHNOLOGY (2018)

Review Immunology

Immunological memory cells

Weronika Ratajczak et al.

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2018)

Article Nanoscience & Nanotechnology

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

Yuanzeng Min et al.

NATURE NANOTECHNOLOGY (2017)

Letter Medicine, General & Internal

Tumor Mutational Burden and Response Rate to PD-1 Inhibition

Mark Yarchoan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Oncology

Cancer nanomedicine: progress, challenges and opportunities

Jinjun Shi et al.

NATURE REVIEWS CANCER (2017)

Review Engineering, Biomedical

Nanomaterials for cancer immunotherapy

Wantong Song et al.

BIOMATERIALS (2017)

Article Biotechnology & Applied Microbiology

Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations

Axel Hoos

NATURE REVIEWS DRUG DISCOVERY (2016)

Review Oncology

In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf

Linda Hammerich et al.

MOLECULAR ONCOLOGY (2015)

Review Chemistry, Multidisciplinary

Programmable nanomedicine: synergistic and sequential drug delivery systems

Dennis B. Pacardo et al.

NANOSCALE (2015)

Article Chemistry, Multidisciplinary

Supramolecular Self-Assembled Nanoparticles Mediate Oral Delivery of Therapeutic TNF-α siRNA against Systemic Inflammation

Lichen Yin et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)

Article Chemistry, Multidisciplinary

On-Demand Drug Release System for InVivo Cancer Treatment through Self-Assembled Magnetic Nanoparticles

Jae-Hyun Lee et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)

Article Pharmacology & Pharmacy

A cross-linked polymeric micellar delivery system for cisplatin(IV) complex

Haiqin Song et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Review Multidisciplinary Sciences

Cancer immunotherapy comes of age

Ira Mellman et al.

NATURE (2011)

Article Chemistry, Applied

Estimation of the surface accessible inclusion sites of β-cyclodextrin based copolymer materials

Mohamed H. Mohamed et al.

CARBOHYDRATE POLYMERS (2010)

Article Biochemistry & Molecular Biology

Necessity of oligonucleotide aggregation for toll-like receptor 9 activation

CCN Wu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)